On 16th December, Supriya Lifescience will initiate its INR 700 crore IPO this week. The Bombay-based API maker intends to issue its stock in the INR 265-274 price band. The offering will consist of the issuance of new equity shares worth INR 200 crore, as well as the offloading of 1.82 crore equity shares worth INR 500 crore by the founder.
Supriya Lifescience is a company that produces active medicinal components. As of 31st March, FY21, the company generates 38 APIs in the analgesic, antihistamine, anesthetic, anti-asthmatic, vitamin & anti-allergic therapeutic segments. In terms of volume, the company is also one of India’s significant exporters of Salbutamol Sulfate in 2021. Between FY17 and FY21, the company was the largest exporter of Ketamine Hydrochloride and Chlorpheniramine Maleate from India.
In FY21, the company’s products were shipped to 1,296 clients, including 346 distributors, in 86 countries. API business is done by the corporation across Europe, Latin America, Asia, and North America.
In the fiscal year 2020-21, the company declared a net profit of INR 123.38 crore, up from INR 73.37 crore the previous year. The company’s revenue increased to INR 396.22 crore in 2021 from INR 327.71 crore the previous year. The company declared a net profit of INR 65.96 crore for the quarter ended September 30, 2021, on revenue of INR 230.06 crore. Axis Capital and ICICI Securities will manage the issue.
Supriya Lifesciences IPO: To buy or not?
Sales of specific products account for a significant portion of Supriya Lifescience earnings. With a presence in over 78 countries, they are a global player. Although the firm has to adhere to a complicated set of rules as per government standards, their competitive strengths include large-scale leadership positions and focus on advanced manufacturing as well as R&D.
Frequently Asked Questions (FAQs)
What is the IPO Price Band for Supriya Lifescience?
The IPO price band for Supriya Lifescience is INR 265 to INR 274 per equity share.
What is the IPO Allotment Date for Supriya Lifescience?
The allotment date for Supriya Lifescience’s initial public offering is December 27, 2021.
When will Supriya Lifescience go public?
The listing date for Supriya Lifescience is December 28, 2021. The IPO will be listed on the BSE and NSE.
What percentage of the IPO is allotted to each investment group?
QIB – 75% of the available shares. Retail – 10% of the available shares must be sold to the general public. NII / HNI – 15% for NII / HNI.
What is the minimum subscription amount for this IPO?
Investors must apply for 54 shares at the lowest price range of INR 265 per share, which equals INR 14,310. Similarly, the minimum amount to be applied on the upper pricing band is INR 274 = INR 14,796.
When will Supriya Lifescience’s initial public offering (IPO) begin?
The Supriya Lifescience initial public offering (IPO) will commence on December 16, 2021, and end on December 20, 2021.
What is the Supriya Lifescience IPO minimum lot size?
The minimum order quantity for the Supriya Lifescience IPO is 54 shares.
[…] Source link […]
[…] post Supriya Lifescience IPO to open on December 16th 2021 appeared first on […]